Back

Antithrombotic treatment in univentricular heart

31 August 2024 (15:00 - 15:50)
Organised by: Logo
Congress Presentation Part of: Optimising care in adult congenital heart disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Ayse-Gul Ozturk

Karolinska Institute, Stockholm (Sweden)

8 More presentations in this session

Presentation thumbnail
Optimising liver screening in patients with a Fontan circulation: a cost-effective approach to detection of Fontan associated liver disease which enhances patient care
Mr H. Mathew (London, GB)
Abstract Slides Video
Presentation thumbnail
Effects of pulmonary hypertension targeted therapy on haemodynamics in pulmonary arterial hypertension associated with adult congenital heart disease: a meta-analysis
Doctor L. Tsigkriki (Chania, GR)
Abstract Slides Video
Presentation thumbnail
A cohort study examining predictors of stroke and bleeding among people with congenital heart disease and atrial fibrillation
Doctor M. O'Shea (Phoenix, US)
Abstract Slides Video
Presentation thumbnail
Reverse cardiac remodeling induced by endovascular treatment of coarctation of the aorta
Assistant Professor M. Farrashi (Tehran, IR)
Abstract Slides Video
Presentation thumbnail
Cardiac resynchronization therapy in adult congenital heart disease: single center cohort study
Doctor O. Rahat (Petah Tikva, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising care in adult congenital heart disease

The Event

Event poster

ESC Congress 2024

31 August 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Late outcomes of Fontan operation from the EUROFONTAN experience
thumbnail
Congress Presentation
Safety and efficacy of prolonged antithrombotic therapy in high-risk patients followed in a dedicated secondary prevention consultation
thumbnail
Congress Presentation
Nationwide observational study of antithrombotic treatment strategies after coronary artery bypass graft surgery in patients with atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources